Research of Akt1 Np_001014431.1:p.e17k has been linked to Malignant Neoplasms, Carcinoma, Neoplasms, Mammary Neoplasms, Malignant Neoplasm Of Ovary. The study of Akt1 Np_001014431.1:p.e17k has been mentioned in research publications which can be found using our bioinformatics tool below. Akt1 Np_001014431.1:p.e17k has been researched in relation to the Cell Proliferation Pathway. This pathway complements our catalog of research reagents for the study of Akt1 Np_001014431.1:p.e17k including antibodies and ELISA kits against AKT1, PIK3CA, PLEK, PTEN, PIK3CB.
Akt1 Np_001014431.1:p.e17k Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Akt1 Np_001014431.1:p.e17k below!
For more information on how to use Laverne, please read the How to Guide.
We have 1446 products for the study of Akt1 Np_001014431.1:p.e17k that can be applied to Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence from our catalog of antibodies and ELISA kits.
Akt1 Np_001014431.1:p.e17k is also known as Akt1 E17k, Akt1 P.e17k.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.